4th Quarter - Report

MR. CARL SCHMID for AIDS INSTITUTE

Firm
Client
Income
$27,500
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Part D, including 6 protected classes, Medicaid funding, Medicaid repeal and replace efforts, Medicaid drug coverage, including Hepatitis C drugs. Medicare and Medicaid coverage of preventive services, including HIV and Hepatitis testing. Medicaid waivers

LobbyistCovered position, as disclosed
CARL E SCHMID —

Contacted: Natl Institutes of Health (NIH); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); White House Office; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Natl AIDS Policy

Health Issues HCR

HIV/AIDS Domestic Programs: Ryan White HIV/AIDS Program, including the AIDS Drug Assistance Program, HIV prevention including HIV testing and syringe services, AIDS housing, healthcare reform, including essential health benefits, high patient cost-sharing, copay assistance and plan design discrimination. health care repeal and replace, hepatitis programs at CDC and HHS; programs addressing infectious diseases associate with the opioid epidemic related to injection drug use.

LobbyistCovered position, as disclosed
CARL E SCHMID —

Contacted: Office of Natl AIDS Policy; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES; White House Office

Budget/Appropriations BUD

HIV/AIDS domestic programs: Ryan White HIV/AIDS Program, including the AIDS Drugs Assistance Program (ADAP), HIV prevention at the CDC, Minority AIDS Initiative, AIDS Research at the NIH, AIDS Housing at HUD. and Hepatitis prevention programs at the CDC, SAMHSA Minority AIDS Initiative programs, Infectious Diseases related to Injection Drug Use and Opioid epidemic

LobbyistCovered position, as disclosed
CARL E SCHMID —

Contacted: White House Office; Natl Institutes of Health (NIH); Office of Natl AIDS Policy; Centers For Disease Control & Prevention (CDC); SENATE; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.